Lifeline Biotechnologies Inc (LLBO)
0.0002
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 0.6278M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | 0.00% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | -- |
Price to Book Value | -- |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | -- |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 98.98% |
Profile
Lifeline Biotechnologies Inc is an US-based company engaged in the business of developing and marketing technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions. It has developed, tested, and patented a process that assists in the identification of dense breast tissue. The process is to be targeted as a screening protocol assisting in the early detection of breast tissue abnormalities and breast cancers. |
URL | http://www.lbti.co |
Investor Relations URL | N/A |
HQ State/Province | Nevada |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Equity Style | N/A |
Next Earnings Release | N/A |
Last Earnings Release | N/A |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Lifeline Biotechnologies Inc is an US-based company engaged in the business of developing and marketing technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions. It has developed, tested, and patented a process that assists in the identification of dense breast tissue. The process is to be targeted as a screening protocol assisting in the early detection of breast tissue abnormalities and breast cancers. |
URL | http://www.lbti.co |
Investor Relations URL | N/A |
HQ State/Province | Nevada |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Equity Style | N/A |
Next Earnings Release | N/A |
Last Earnings Release | N/A |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |